UK-based company now offers services from development to cGMP-compliant production
Photo from video on company website
Concept Life Sciences has unveiled a new clinical niche commercial facility. The facility has been designed to support pharma and biotech companies throughout the development and manufacture of active pharmaceutical ingredients (API).
Located at Discovery Park in Sandwich, UK, the purpose-built facility offers a comprehensive range of services designed to allow partner organisations to take drug candidates through discovery, scale up and into cGMP-compliant production.
Dr Paul Doyle, Chief Scientific Officer at Concept Life Sciences said: “Pharmaceutical and biotech companies of all sizes are demanding high-quality, early-stage manufacturing capabilities that can readily scale up target molecules from grams to kilograms, and then into cGMP-compliant API manufacture all while mitigating the risk typically associated with moving between different stages of the drug development process."
Doyle continued to say that the new specialist facility will strengthen support services to enable a boost in productivity and faster time to market.
With the new facility joining the company’s growing network of sites across the UK, Concept Life Sciences’ pharmaceutical manufacturing support services now comprise: